These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8264140)

  • 21. A single-base mutation in exon 31 converting glycine 852 to arginine in the collagenous domain in an Alport syndrome patient.
    Kawai S; Nomura S; Harano T; Harano K; Fukushima T; Wago M; Shimizu B; Osawa G
    Nephron; 1996; 74(2):333-6. PubMed ID: 8893151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete amino acid sequence of the human alpha 5 (IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient.
    Zhou J; Hertz JM; Leinonen A; Tryggvason K
    J Biol Chem; 1992 Jun; 267(18):12475-81. PubMed ID: 1352287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in the codon for a conserved arginine-1563 in the COL4A5 collagen gene in Alport syndrome.
    Zhou J; Gregory MC; Hertz JM; Barker DF; Atkin C; Spencer ES; Tryggvason K
    Kidney Int; 1993 Mar; 43(3):722-9. PubMed ID: 8455372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome.
    Renieri A; Seri M; Myers JC; Pihlajaniemi T; Massella L; Rizzoni G; De Marchi M
    Hum Mol Genet; 1992 May; 1(2):127-9. PubMed ID: 1363780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing.
    Martin P; Heiskari N; Zhou J; Leinonen A; Tumelius T; Hertz JM; Barker D; Gregory M; Atkin C; Styrkarsdottir U; Neumann H; Springate J; Shows T; Pettersson E; Tryggvason K
    J Am Soc Nephrol; 1998 Dec; 9(12):2291-301. PubMed ID: 9848783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single base pair deletions in exons 39 and 42 of the COL4A5 gene in Alport syndrome.
    Renieri A; Galli L; De Marchi M; Li Volti S; Mollica F; Lupo A; Maschio G; Peissel B; Rossetti S; Pignatti P
    Hum Mol Genet; 1994 Jan; 3(1):201-2. PubMed ID: 8162029
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel splice site mutation in the COL4A5 gene in a Chinese female patient with rare ocular abnormalities.
    Zhao C; Wang F; Zhang Y; Wen Y; Su Y; Zhang C; Sui R; Xu F; Ding J; Dong F
    Mol Vis; 2012; 18():2205-12. PubMed ID: 22919268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.
    Renieri A; Bruttini M; Galli L; Zanelli P; Neri T; Rossetti S; Turco A; Heiskari N; Zhou J; Gusmano R; Massella L; Banfi G; Scolari F; Sessa A; Rizzoni G; Tryggvason K; Pignatti PF; Savi M; Ballabio A; De Marchi M
    Am J Hum Genet; 1996 Jun; 58(6):1192-204. PubMed ID: 8651296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
    Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
    Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel missense mutation in exon 3 of the COL4A5 gene associated with late-onset Alport syndrome.
    Turco AE; Rossetti S; Biasi MO; Rizzoni G; Massella L; Saarinen NH; Renieri A; Pignatti PF; De Marchi M
    Clin Genet; 1995 Nov; 48(5):261-3. PubMed ID: 8825605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
    Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
    Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome.
    Ueki Y; Naito I; Oohashi T; Sugimoto M; Seki T; Yoshioka H; Sado Y; Sato H; Sawai T; Sasaki F; Matsuoka M; Fukuda S; Ninomiya Y
    Am J Hum Genet; 1998 Feb; 62(2):253-61. PubMed ID: 9463311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An 8 bp deletion in exon 51 of the COL4A5 gene of an Alport syndrome patient.
    Boye E; Flinter FA; Bobrow M; Harris A
    Hum Mol Genet; 1993 May; 2(5):595-6. PubMed ID: 8518800
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential splicing of COL4A5 mRNA in kidney and white blood cells: a complex mutation in the COL4A5 gene of an Alport patient deletes the NC1 domain.
    Guo C; Van Damme B; Van Damme-Lombaerts R; Van den Berghe H; Cassiman JJ; Marynen P
    Kidney Int; 1993 Dec; 44(6):1316-21. PubMed ID: 8301933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours.
    Heidet L; Dahan K; Zhou J; Xu Z; Cochat P; Gould JD; Leppig KA; Proesmans W; Guyot C; Guillot M
    Hum Mol Genet; 1995 Jan; 4(1):99-108. PubMed ID: 7711741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant splicing of the COL4A5 gene in patients with Alport syndrome.
    Lemmink HH; Kluijtmans LA; Brunner HG; Schröder CH; Knebelmann B; Jelínková E; van Oost BA; Monnens LA; Smeets HJ
    Hum Mol Genet; 1994 Feb; 3(2):317-22. PubMed ID: 8004101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unequal homologous crossing over resulting in duplication of 36 base pairs within exon 47 of the COL4A5 gene in a family with Alport syndrome.
    Hämäläinen ER; Renieri A; Pecoraro C; De Marchi M; Pihlajaniemi T
    Hum Mutat; 1996; 8(3):265-9. PubMed ID: 8889587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.